Alyeska Investment Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,997
| Closed | -$3.04M | – | 647 |
|
|
2024
Q4 | $3.04M | Sell |
24,997
-210,243
| -89% | -$25.6M | 0.01% | 441 |
|
|
2024
Q3 | $29.4M | Buy |
235,240
+175,240
| +292% | +$21.9M | 0.15% | 197 |
|
|
2024
Q2 | $9.48M | Buy |
+60,000
| New | +$9.48M | 0.05% | 275 |
|
|
2023
Q3 | – | Sell |
-27,869
| Closed | -$3.19M | – | 590 |
|
|
2023
Q2 | $3.19M | Buy |
+27,869
| New | +$3.19M | 0.02% | 352 |
|
|
2020
Q2 | – | Sell |
-4,708
| Closed | -$461K | – | 543 |
|
|
2020
Q1 | $461K | Sell |
4,708
-283,659
| -98% | -$27.8M | 0.01% | 311 |
|
|
2019
Q4 | $37.2M | Sell |
288,367
-186,887
| -39% | -$24.1M | 0.49% | 74 |
|
|
2019
Q3 | $35.8M | Buy |
475,254
+93,319
| +24% | +$7.03M | 0.52% | 65 |
|
|
2019
Q2 | $58M | Sell |
381,935
-20,357
| -5% | -$3.09M | 0.75% | 37 |
|
|
2019
Q1 | $47.9M | Buy |
402,292
+130,002
| +48% | +$15.5M | 0.63% | 46 |
|
|
2018
Q4 | $29.7M | Sell |
272,290
-102,092
| -27% | -$11.1M | 0.43% | 87 |
|
|
2018
Q3 | $60.5M | Sell |
374,382
-78,842
| -17% | -$12.7M | 0.66% | 49 |
|
|
2018
Q2 | $59.9M | Buy |
453,224
+272,943
| +151% | +$36.1M | 0.54% | 66 |
|
|
2018
Q1 | $13.4M | Sell |
180,281
-871,192
| -83% | -$64.5M | 0.11% | 190 |
|
|
2017
Q4 | $58.5M | Buy |
1,051,473
+478,033
| +83% | +$26.6M | 0.47% | 76 |
|
|
2017
Q3 | $26M | Buy |
+573,440
| New | +$26M | 0.19% | 149 |
|